Sheela Foam Appoints Neeraj Jain as Independent Director from May 14, 2026
Sheela Foam Limited appointed Mr. Neeraj Jain as an Independent Director. His tenure begins on May 14, 2026, for five years, pending shareholder approval. Mr. Jain brings over 35 years of experience in finance and management.
The appointment of an independent director can positively influence corporate governance and strategic decision-making, which has a medium-term impact on the company's operations and stakeholder confidence.
The appointment of an experienced director is generally viewed positively as it can strengthen the company's governance and strategic direction.
Sheela Foam Limited has announced the appointment of Mr. Neeraj Jain (DIN: 00348591) as an Additional Director in the category of Independent Director. This decision was approved by the Board of Directors based on the recommendation of the Nomination & Remuneration Committee.
Mr. Jain's appointment is effective from May 14, 2026, and he is set to hold the office for a period of five consecutive years, subject to the approval of the Shareholders. This appointment is made in accordance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Mr. Neeraj Jain is a Chartered Accountant and Company Secretary with over 35 years of extensive experience in finance, management, governance, and strategy. He has held senior leadership positions, including Chief Financial Officer at Johnson & Johnson Medical India and General Manager at Hindustan Unilever Limited. His expertise spans financial stewardship, corporate governance, risk management, strategic planning, mergers and acquisitions, and compliance management. Mr. Jain is not related to any of the current Directors of Sheela Foam Limited and is not debarred from holding any directorship by any regulatory authority.
What to do with a filing like this
Sheela Foam Limited filed this with the NSE as a statutory disclosure, categorised under board changes. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Sheela Foam Limited. Read the original for the full detail.